GlassScriptPhysician profile
Tracey L Smith
NPI 1790107357
$1,514.10
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $912 · 2022: $218 · 2023: $384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $383.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $266.75 | 2021-2022 | |
| Forte Bio-Pharma LLC | $239.42 | 2021-2023 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $225.15 | 2021-2023 | Ztlido |
| Biodelivery Sciences International, INC. | $153.00 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $151.07 | 2021-2023 | Relistor |
| Lilly USA, LLC | $95.94 | 2021-2023 | Emgality, Reyvow |
| Braeburn INC. | $57.42 | 2023 | Brixadi |
| Pfizer INC. | $52.72 | 2021 | |
| Arbor Pharmaceuticals, INC. | $50.45 | 2021 | |
| Virtus Pharmaceuticals LLC | $48.20 | 2023 | Levorphanol Tartrate |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $38.96 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $23.41 | 2021 | |
| Indivior INC. | $22.98 | 2021 | |
| Grt US Holding, INC. | $19.94 | 2022 | |
| Azurity Pharmaceuticals, INC. | $16.88 | 2023 | Horizant |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.39 | 2021 | |
| Upsher-Smith Laboratories LLC | $12.93 | 2021 | |
| Redhill Biopharma INC. | $12.64 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracey Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.